In the present study, we examined the expression of Kaiso in 294 cases non-small cell lung cancers (NSCLC) and analyzed the correlation between expression of Kaiso and clinicopathological factors. This evidence concerns the gene ZBTB33 and non-small cell lung carcinoma.